You are here:

Home
NICE Guidance
Conditions and diseases
Cystic fibrosis

Cystic fibrosis Products

A list of all our products on cystic fibrosis

Filter

Product type

Product typeGuidanceQuality standardsAdvice

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidanceMedical technologies guidance

Status
1 selected

StatusPublishedIn developmentAwaiting developmentTopic selection

Showing 1 product

Sort by: Date | Sort by Title

Status: Awaiting developmentRemove ‘Status: Awaiting development’ filter

Elexacaftor–tezacaftor–ivacaftor with ivacaftor for treating cystic fibrosis without an F508del mutation and with a mutation in the CFTR gene that is responsive to elexacaftor–tezacaftor–ivacaftor in people aged 6 and over [TSID11847]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC